Johns Hopkins’ Cerebral Fluid Center is among the few in the United States that can diagnose and treat the full spectrum of such disorders.

Developed at Johns Hopkins, a next-generation technique helps neurologists identify hard-to-diagnose brain infections. Johns Hopkins is one of the few academic medical centers offering the approach in the U.S.

Study by Johns Hopkins and Tel Aviv University scientists suggests that immune molecule P-selectin could play a key role in deadly brain tumors.

By following certain patients for long periods — sometimes from childhood through adulthood — the Johns Hopkins epilepsy team helps protect patients from problems that can occur during various stages of their lives.